Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years due to Washington's insistence on sensitive biological samples.
This move became public after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative has since stated that the US was requesting biological samples for research and commercial purposes while was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for more dialogue to find a deal agreeable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Implications
This development comes after a comparable case in Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
After resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and responsibility.
According to statements, 16 nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our nation would provide the basic resources for scientific discovery without any assurance that the end products would be available to our citizens should a future disease outbreak emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures already established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system created to deal with potential pandemics.
"This system is designed to guarantee that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage further dialogue with our US partners on how subsequent collaboration might be designed in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body stated it recognised the government's concerns, but suggested that talks need to persist given that a large portion of the nation's HIV programmes relied on international support.
"If technical issues arise, including those involving information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.
The halted deal emphasises the complex debate between accepting vital international aid and safeguarding local interests in an increasingly interconnected world.